Both drugs can cause side effects like nausea and diarrhea, and they may increase the risk of serious conditions such as pancreatitis and thyroid cancer
What is BPC-157 and where does it come from
25:335-58 Bell DA, Taylor JA, Paulson DF, Robertson CN
Novo Nordisk filed the New Drug Application (NDA) for CagriSema in early 2026, based on positive results from the REDEFINE phase 3 trial program
These medications influence satiety, gastric emptying, insulin response, glucagon regulation, and central appetite signaling
Limiting smoking, excessive alcohol consumption, and prolonged sun exposure may also support overall wellness